| Mrs Elizabeth A Herlihy, DPT | |
|
150 Gentilly Blvd, Cartersville, GA 30120-8522 | |
| (678) 719-7000 | |
| (678) 719-7003 |
| Full Name | Mrs Elizabeth A Herlihy |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 12 Years |
| Location | 150 Gentilly Blvd, Cartersville, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063756534 | NPI | - | NPPES |
| 13638326 | Other | GA | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT010866 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Orthopedics, Llc | 4385963172 | 149 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Provider Name | Orthoatlanta, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851937114 PECOS PAC ID: 3971406885 Enrollment ID: O20040129000005 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Provider Name | Emory Physical Therapy, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922018423 PECOS PAC ID: 1153382676 Enrollment ID: O20041019000776 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Provider Name | The Weston Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841309101 PECOS PAC ID: 8123936796 Enrollment ID: O20050719000195 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Provider Name | Horizons Therapy Group, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720373020 PECOS PAC ID: 5496781627 Enrollment ID: O20110621000685 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Provider Name | Paxxon Healthcare Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1386917532 PECOS PAC ID: 8325959554 Enrollment ID: O20120409000213 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Provider Name | Piedmont Orthopedics, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114317062 PECOS PAC ID: 4385963172 Enrollment ID: O20150429000361 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Provider Name | Georgia Luna Care Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245826999 PECOS PAC ID: 4082027727 Enrollment ID: O20210119001811 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Elizabeth A Herlihy, DPT 80 Technacenter Dr, Suite 300, Montgomery, AL 36117-6028 Ph: (334) 625-5795 | Mrs Elizabeth A Herlihy, DPT 150 Gentilly Blvd, Cartersville, GA 30120-8522 Ph: (678) 719-7000 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
Having experienced a death of a child in his family due to leukemia, Warren Sulmasy made a donation to St. Jude Children's Research Hospital in February 2013.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In a new study from the Wake Forest Institute for Regenerative Medicine researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
› Verified 1 days ago
Ariel Larocca, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 650 Henderson Dr Ste 301, Cartersville, GA 30120 Phone: 678-721-9922 | |
Mr. Igor Oruc, D.P.T Physical Therapist Medicare: Medicare Enrolled Practice Location: 150 Gentilly Blvd, Cartersville, GA 30120 Phone: 678-719-7000 Fax: 678-719-7003 | |
Anna Gilbert Anello, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 Gentilly Blvd, Cartersville, GA 30120 Phone: 678-719-7000 Fax: 678-719-7003 | |
Taylor Mote, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 Market Place Blvd, Cartersville, GA 30121 Phone: 470-210-1164 | |
Daniel G Pernell, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 150 Gentilly Blvd, Cartersville, GA 30120 Phone: 678-719-7000 Fax: 678-719-7003 | |
Pt Solutions Of Acworth Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 650 Henderson Dr, Suite 301, Cartersville, GA 30120 Phone: 678-721-9922 Fax: 670-721-7799 |